Gilead Sciences, Inc.
Proposal 1a.
Election of Director to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1b.
Election of Director to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1c.
Election of Director to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1d.
Election of Director to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1e.
Election of Director to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1f.
Election of Director to serve for the next year and until their successors are elected and qualified: Harish Manwani
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1g.
Election of Director to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1h.
Election of Director to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1i.
Election of Director to serve for the next year and until their successors are elected and qualified: Anthony Welters
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 2.
To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 3.
To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 4.
To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 5.
To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 6.
To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 7.
To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting.
Caisse vote:
Against
Applicable policy or principle:
PDV_01